Akanda Corp. (AKAN)
$0.5301
-0.04 (-7.16%)
Rating:
Recommendation:
-
| Symbol | AKAN |
|---|---|
| Price | $0.5301 |
| Beta | 0.000 |
| Volume Avg. | 0.45M |
| Market Cap | 2.059M |
| Shares () | - |
| 52 Week Range | 0.44-6.35 |
| 1y Target Est | - |
| DCF Unlevered | AKAN DCF -> | |
|---|---|---|
| DCF Levered | AKAN LDCF -> | |
| ROE | 3.22% | Neutral |
| ROA | 1.02% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 14.50% | Neutral |
| P/E | -0.19 | Neutral |
| P/B | 0.06 | Neutral |
Latest AKAN news
About
Download (Excel)Ms. Katharyn Field
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.